CDK4 and neoplasm: Absence of p21 in tumor cells sensitized KC cell lines to palbociclib with an increase in CDK4 signaling (Supplemental Figure 4, G and H), emphasizing that p21-mediated CDK4 dysregulation was independent of p53 control.